论文标题
制药行业对欧洲国家创新绩效的影响
The Impact of the Pharmaceutical Industry on the Innovation Performance of European Countries
论文作者
论文摘要
国家之间的创新绩效存在显着差异。此外，某些国家 /地区的制药部门比其他国家要强大。这表明制药行业的发展会影响一个国家的创新绩效。使用全球创新指数和选定的制药行业绩效指标，本研究研究了药物领域如何影响欧洲背景下国家的创新绩效。使用简单和多个线性回归和Pearson相关性分析了27个欧洲国家的数据集。我们的发现表明，制药行业只有三个指标，更精确的制药研究和开发，药品出口和制药就业，这在很大程度上解释了一个国家的创新绩效。制药研究，开发和出口对一个国家的创新绩效产生了重大积极影响，而在制药行业的就业影响略有负面影响。此外，已经发现全球创新绩效对预期寿命产生积极影响。我们进一步概述了基于这些发现的含义和可能的政策指示。
There are significant differences in innovation performance between countries. Additionally, the pharmaceutical sector is stronger in some countries than in others. This suggests that the development of the pharmaceutical industry can influence a country's innovation performance. Using the Global Innovation Index and selected performance measures of the pharmaceutical sector, this study examines how the pharmaceutical sector influences the innovation performance of countries from the European context. The dataset of 27 European countries was analysed using simple, and multiple linear regressions and Pearson correlation. Our findings show that only three indicators of the pharmaceutical industry, more precisely pharmaceutical Research and Development, pharmaceutical exports, and pharmaceutical employment explain the innovation performance of a country largely. Pharmaceutical Research and Development and exports have a significant positive impact on a country's innovation performance, whereas employment in the pharmaceutical industry has a slightly negative impact. Additionally, global innovation performance has been found to positively influence life expectancy. We further outline the implications and possible policy directions based on these findings.
